# Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects

> **NCT03466736** · — · COMPLETED · sponsor: **University of Utah** · enrollment: 165 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **DIAGNOSTIC_TEST:** [18F]flutemetamol PET scan

## Key facts

- **NCT ID:** NCT03466736
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2023-04-20
- **Final completion:** 2023-04-20
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2023-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03466736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03466736, "Enriching Clinical Trials Requiring Amyloid Positivity With Practice Effects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03466736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*